DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
PG2
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
PG2
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PELACARSEN
2
Oligonucleotide
Investigational
Unknown
Unknown
Kidney Diseases; Cardiovascular Diseases
Unknown
PELACARSEN
×
Maximum Phase:
2
First Approval:
None
UNII:
LSO9H7UZ90
Molecule Type:
Oligonucleotide
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
JNJ-18038683
2
Small molecule
Investigational
Unknown
Unknown
Bipolar Disorder; Depressive Disorder, Major
Serotonin 7 (5-HT7) receptor antagonist
JNJ-18038683
×
Maximum Phase:
2
First Approval:
None
UNII:
28PGH5X4OQ
Molecule Type:
Small molecule
Molecular Formula:
C20H20ClN3
Molecular Weight:
337.85
AlogP:
3.94
PSA:
29.85
HBD:
1.0
HBA:
#RotB:
3.0
Source:
TD-1792
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
TD-1792
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CPI-0610
2
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Lymphoma; Multiple Myeloma; Myelodysplastic Syndromes; Primary Myelofibrosis; Peripheral Nervous System Neoplasms
Bromodomain and extra-terminal motif (BET) inhibitor
CPI-0610
×
Maximum Phase:
2
First Approval:
None
UNII:
U4017GUQ06
Molecule Type:
Small molecule
Molecular Formula:
C20H16ClN3O2
Molecular Weight:
365.82
AlogP:
4.07
PSA:
81.48
HBD:
1.0
HBA:
#RotB:
3.0
Source:
BNC-210
2
Unknown
Investigational
Unknown
Unknown
Psychomotor Agitation; Stress Disorders, Post-Traumatic
Unknown
BNC-210
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BIRICODAR DICITRATE
2
Small molecule
Investigational
Unknown
Unknown
Lung Neoplasms
Unknown
BIRICODAR DICITRATE
×
Maximum Phase:
2
First Approval:
None
UNII:
9WQP0L619L
Molecule Type:
Small molecule
Molecular Formula:
C46H57N3O21
Molecular Weight:
987.96
AlogP:
5.02
PSA:
117.15
HBD:
0.0
HBA:
#RotB:
15.0
Source:
VAROGLUTAMSTAT
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Unknown
VAROGLUTAMSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
E3DSH8LL4L
Molecule Type:
Small molecule
Molecular Formula:
C19H20N4O2
Molecular Weight:
336.4
AlogP:
3.62
PSA:
70.25
HBD:
2.0
HBA:
#RotB:
5.0
Source:
MEM 3454
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MEM 3454
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FIACITABINE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FIACITABINE
×
Maximum Phase:
2
First Approval:
None
UNII:
4058H365ZB
Molecule Type:
Small molecule
Molecular Formula:
C9H11FIN3O4
Molecular Weight:
371.11
AlogP:
-0.98
PSA:
110.6
HBD:
3.0
HBA:
#RotB:
2.0
Source:
MK-4280
2
Unknown
Investigational
Unknown
Unknown
Carcinoma, Renal Cell; Hodgkin Disease; Lymphoma, Non-Hodgkin; Neoplasms; Small Cell Lung Carcinoma; Carcinoma, Non-Small-Cell Lung
Lymphocyte activation gene 3 protein inhibitor
MK-4280
×
Maximum Phase:
2
First Approval:
None
UNII:
H1396W7D1H
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
S-ADENOSYL-L-METHIONINE
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C; Tobacco Use Disorder
Unknown
S-ADENOSYL-L-METHIONINE
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C15H22N6O5S
Molecular Weight:
398.45
AlogP:
-3.26
PSA:
185.46
HBD:
4.0
HBA:
#RotB:
7.0
Source:
IMALUMAB
2
Antibody
Investigational
Unknown
Unknown
Unknown
Macrophage migration inhibitory factor inhibitor
IMALUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
22F97PC79G
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VATIQUINONE
2
Small molecule
Investigational
Unknown
Unknown
Muscular Diseases; Tourette Syndrome; Child Development Disorders, Pervasive; Friedreich Ataxia; Hearing Loss, Noise-Induced; Leigh Disease; Mitochondrial Diseases; Parkinson Disease; Rett Syndrome
Quinone reductase 1) modulator
VATIQUINONE
×
Maximum Phase:
2
First Approval:
None
UNII:
6O85FK9I0X
Molecule Type:
Small molecule
Molecular Formula:
C29H44O3
Molecular Weight:
440.67
AlogP:
7.52
PSA:
54.37
HBD:
1.0
HBA:
#RotB:
12.0
Source:
CANTUZUMAB RAVTANSINE
2
Antibody
Investigational
Unknown
Unknown
Colorectal Neoplasms; Pancreatic Neoplasms; Stomach Neoplasms
Mucin-1 binding agent
CANTUZUMAB RAVTANSINE
×
Maximum Phase:
2
First Approval:
None
UNII:
RNQ8JQ4R9P
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NEFIRACETAM
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Unknown
NEFIRACETAM
×
Maximum Phase:
2
First Approval:
None
UNII:
1JK12GX30N
Molecule Type:
Small molecule
Molecular Formula:
C14H18N2O2
Molecular Weight:
246.31
AlogP:
1.86
PSA:
49.41
HBD:
1.0
HBA:
#RotB:
3.0
Source:
RO4998452
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RO4998452
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-817399
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid
C-C chemokine receptor type 1 antagonist
BMS-817399
×
Maximum Phase:
2
First Approval:
None
UNII:
AKQ3X6FEH0
Molecule Type:
Small molecule
Molecular Formula:
C23H36ClN3O4
Molecular Weight:
454.01
AlogP:
2.88
PSA:
101.9
HBD:
4.0
HBA:
#RotB:
6.0
Source:
ELZASONAN
2
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder, Major
Unknown
ELZASONAN
×
Maximum Phase:
2
First Approval:
None
UNII:
933PJL964R
Molecule Type:
Small molecule
Molecular Formula:
C22H23Cl2N3OS
Molecular Weight:
448.42
AlogP:
4.87
PSA:
26.79
HBD:
0.0
HBA:
#RotB:
3.0
Source:
VAPENDAVIR
2
Small molecule
Investigational
Unknown
Unknown
Asthma
VP1 capsid protein inhibitor
VAPENDAVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
Q8LVL5Z68H
Molecule Type:
Small molecule
Molecular Formula:
C21H26N4O3
Molecular Weight:
382.46
AlogP:
4.01
PSA:
73.51
HBD:
0.0
HBA:
#RotB:
7.0
Source:
ROZIBAFUSP ALFA
2
Protein
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Lupus Erythematosus, Systemic
Unknown
ROZIBAFUSP ALFA
×
Maximum Phase:
2
First Approval:
None
UNII:
O9YF5SN7KL
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LCB01-0371
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LCB01-0371
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IVA337
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
IVA337
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TALAMPANEL
2
Small molecule
Investigational
Unknown
Unknown
Amyotrophic Lateral Sclerosis; Astrocytoma; Central Nervous System Neoplasms; Epilepsy; Glioblastoma; Oligodendroglioma; Parkinson Disease
Glutamate receptor ionotropic, AMPA 1 antagonist
TALAMPANEL
×
Maximum Phase:
2
First Approval:
None
UNII:
CVS43XG1L5
Molecule Type:
Small molecule
Molecular Formula:
C19H19N3O3
Molecular Weight:
337.38
AlogP:
2.54
PSA:
77.15
HBD:
1.0
HBA:
#RotB:
1.0
Source:
CHROMIUM NICOTINATE
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
CHROMIUM NICOTINATE
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VIDOFLUDIMUS
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Cholangitis, Sclerosing; Colitis, Ulcerative; Inflammatory Bowel Diseases; Multiple Sclerosis; Severe Acute Respiratory Syndrome
Dihydroorotate dehydrogenase inhibitor
VIDOFLUDIMUS
×
Maximum Phase:
2
First Approval:
None
UNII:
8Y1PJ3VG81
Molecule Type:
Small molecule
Molecular Formula:
C20H18FNO4
Molecular Weight:
355.37
AlogP:
4.0
PSA:
75.63
HBD:
2.0
HBA:
#RotB:
5.0
Source:
18F-DTBZ
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
18F-DTBZ
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IMARADENANT
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Neoplasms; Prostatic Neoplasms, Castration-Resistant
Adenosine A2a receptor antagonist
IMARADENANT
×
Maximum Phase:
2
First Approval:
None
UNII:
770140J08A
Molecule Type:
Small molecule
Molecular Formula:
C15H11ClFN5
Molecular Weight:
315.74
AlogP:
3.28
PSA:
77.58
HBD:
1.0
HBA:
#RotB:
2.0
Source:
ALFLUTINIB
2
Small molecule
Investigational
Unknown
Unknown
Adenocarcinoma of Lung; Carcinoma, Non-Small-Cell Lung
Epidermal growth factor receptor erbB1 inhibitor
ALFLUTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
A49A7A5YN4
Molecule Type:
Small molecule
Molecular Formula:
C28H31F3N8O2
Molecular Weight:
568.6
AlogP:
4.84
PSA:
100.44
HBD:
2.0
HBA:
#RotB:
11.0
Source:
TEBANICLINE TOSYLATE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Neuronal acetylcholine receptor; alpha4/beta2 agonist
TEBANICLINE TOSYLATE
×
Maximum Phase:
2
First Approval:
None
UNII:
CP1A26546Z
Molecule Type:
Small molecule
Molecular Formula:
C16H19ClN2O4S
Molecular Weight:
370.86
AlogP:
1.48
PSA:
34.15
HBD:
1.0
HBA:
#RotB:
3.0
Source:
SELONSERTIB
2
Small molecule
Investigational
Unknown
Unknown
Diabetic Nephropathies; Hepatitis, Alcoholic; Hypertension, Pulmonary
Mitogen-activated protein kinase kinase kinase 5 inhibitor
SELONSERTIB
×
Maximum Phase:
2
First Approval:
None
UNII:
NS3988A2TC
Molecule Type:
Small molecule
Molecular Formula:
C24H24FN7O
Molecular Weight:
445.5
AlogP:
4.68
PSA:
90.52
HBD:
1.0
HBA:
#RotB:
6.0
Source:
PALTUSOTINE
2
Unknown
Investigational
Unknown
Unknown
Acromegaly
Unknown
PALTUSOTINE
×
Maximum Phase:
2
First Approval:
None
UNII:
F2IBD1GMD3
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PHORBOL MYRISTATE ACETATE
2
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Leukemia
Unknown
PHORBOL MYRISTATE ACETATE
×
Maximum Phase:
2
First Approval:
None
UNII:
NI40JAQ945
Molecule Type:
Small molecule
Molecular Formula:
C36H56O8
Molecular Weight:
616.84
AlogP:
5.75
PSA:
130.36
HBD:
3.0
HBA:
#RotB:
15.0
Source:
ONO-2952
2
Small molecule
Investigational
Unknown
Unknown
Irritable Bowel Syndrome
Translocator protein antagonist
ONO-2952
×
Maximum Phase:
2
First Approval:
None
UNII:
ZH8CPX4YNB
Molecule Type:
Small molecule
Molecular Formula:
C22H20ClFN2O2
Molecular Weight:
398.87
AlogP:
4.95
PSA:
45.33
HBD:
1.0
HBA:
#RotB:
2.0
Source:
EMVODODSTAT
2
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Leukemia, Myeloid, Acute; Neoplasms; Neurofibromatosis 2
Unknown
EMVODODSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C25H20Cl2N2O3
Molecular Weight:
467.35
AlogP:
6.63
PSA:
54.56
HBD:
1.0
HBA:
#RotB:
3.0
Source:
1
2
…
182
183
184
185
186
187
188
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA